Back to search
FDAFDA · Food and drugs·Recall number D-1388-2019

Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 20-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 43023 1

Published June 26, 2019 · Recall initiated: June 5, 2019

Summary

FDA records drug Class II recall D-1388-2019, published June 26, 2019 and initiated June 5, 2019. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 17,136 20-count units; Lot: Lot GKT0791, EXP 06/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sun Pharmaceutical Industries, Inc.
Distributor
Nationwide in the USA
Lot
Lot GKT0791, EXP 06/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 20-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 43023 1 recalled?

Yes. FDA published recall D-1388-2019 on June 26, 2019. Reported hazard: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter